Dyne Immune Institute for Translational Medicine and Research
A small research organization focused on rapid pathogen detection, ultra‑sensitive antigen assays, and translational efforts for prophylaxis and remediation of infectious disease. The institute develops point‑of‑care and automated laboratory screening formats for clinical, environmental, veterinary and defense applications and seeks R&D and licensing collaborations.
Industries
Nr. of Employees
small (1-50)
Dyne Immune Institute for Translational Medicine and Research
Products
Rapid early‑detection field assay and automated laboratory screening platform (under development)
A platform family including non‑instrument field assays for on‑site antemortem screening and automated laboratory equipment for high‑throughput pathogen screening; intended to provide faster turnaround than standard culture or instrument‑based PCR workflows.
Rapid early‑detection field assay and automated laboratory screening platform (under development)
A platform family including non‑instrument field assays for on‑site antemortem screening and automated laboratory equipment for high‑throughput pathogen screening; intended to provide faster turnaround than standard culture or instrument‑based PCR workflows.
Services
Provision of rapid screening assays in non‑instrument field kits and automated laboratory formats for clinical, environmental and veterinary pathogen surveillance.
Research and development programs focused on post‑exposure prophylaxis systems and prophylactic/vaccine technologies for public health and defense applications.
Provision of rapid screening assays in non‑instrument field kits and automated laboratory formats for clinical, environmental and veterinary pathogen surveillance.
Research and development programs focused on post‑exposure prophylaxis systems and prophylactic/vaccine technologies for public health and defense applications.
Expertise Areas
- Rapid pathogen detection and point‑of‑care assays
- Immunoassay development and ultra‑sensitive antigen detection
- Clinical screening workflows and infection control
- Environmental surveillance for nosocomial infection reduction
Key Technologies
- Immunoassays
- Photon‑counting detection methods
- Point‑of‑care non‑instrument test kits
- Automated high‑throughput laboratory screening platforms
News & Updates
Announcement of joining a consortium to advance development efforts supporting DoD medical pharmaceutical and diagnostic requirements related to CBRN threats; stated objectives include early detection field assays and prophylactic/vaccine technology.
Announcement of joining a consortium to advance development efforts supporting DoD medical pharmaceutical and diagnostic requirements related to CBRN threats; stated objectives include early detection field assays and prophylactic/vaccine technology.